Cost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancer

Ali McBride, Karen MacDonald, Adolfo Fuentes-Alburo, Ivo Abraham

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences